antalarmin has been researched along with nbi 27914 in 2 studies
| Studies (antalarmin) | Trials (antalarmin) | Recent Studies (post-2010) (antalarmin) | Studies (nbi 27914) | Trials (nbi 27914) | Recent Studies (post-2010) (nbi 27914) |
|---|---|---|---|---|---|
| 181 | 0 | 76 | 76 | 0 | 29 |
| Protein | Taxonomy | antalarmin (IC50) | nbi 27914 (IC50) |
|---|---|---|---|
| Bile acid receptor | Homo sapiens (human) | 2.77 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilligan, PJ; Robertson, DW; Zaczek, R | 1 |
| Crowe, PD; Grigoriadis, DE; Hoare, SR; Ling, N; Schwarz, DA; Sullivan, SK; Vale, WW | 1 |
1 review(s) available for antalarmin and nbi 27914
| Article | Year |
|---|---|
Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents.
Topics: Amino Acid Sequence; Animals; Humans; Molecular Sequence Data; Receptors, Corticotropin-Releasing Hormone; Stress, Physiological | 2000 |
1 other study(ies) available for antalarmin and nbi 27914
| Article | Year |
|---|---|
Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
Topics: Amphibian Proteins; Aniline Compounds; Animals; Binding, Competitive; Cell Line; Corticotropin-Releasing Hormone; Extracellular Space; GTP-Binding Proteins; Humans; Ligands; Models, Chemical; Peptide Fragments; Peptide Hormones; Peptides; Protein Binding; Protein Structure, Tertiary; Pyrazoles; Pyrimidines; Pyrroles; Rats; Receptors, Corticotropin-Releasing Hormone; Triazines; Urocortins | 2004 |